| Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
| Live birth rates | |||||
|
Systematic review |
Women with unexplained recurrent miscarriage 8 RCTs in this analysis |
Proportion of women having a live birth
92/159 (58%) with intravenous immunoglobulin 85/144 (59%) with placebo |
OR 0.98 95% CI 0.61 to 1.58 P = 0.94 This analysis was not ITT A sensitivity analysis of RCTs reporting an ITT analysis also found no significant difference between groups (4 RCTs, 279 women, OR 1.18, 95% CI 0.72 to 1.93) See Further information on studies |
Not significant | |
|
Systematic review |
Women with unexplained recurrent miscarriage 6 RCTs in this analysis |
Live birth rate per participant randomised
88/139 (63%) with intravenous immunoglobulin 87/133 (65%) with placebo |
OR 0.92 95% CI 0.55 to 1.54 P = 0.30 The review also performed a sub-group analysis by type of miscarriage and treatment start time (see Further information on studies) |
Not significant |